Nonvascular Thoracic MRI Improves Clinical Decision Making

Share this content:
Nonvascular Thoracic MRI Improves Clinical Decision Making
Nonvascular Thoracic MRI Improves Clinical Decision Making

THURSDAY, July 28, 2016 (HealthDay News) -- Assessment with nonvascular thoracic magnetic resonance (MR) imaging improves clinical decision making, according to a study published in the August issue of Radiology.

Jeanne B. Ackman, M.D., from Massachusetts General Hospital in Boston, and colleagues examined the impact of nonvascular thoracic MR imaging on the clinical decision making and diagnostic certainty of thoracic surgeons. Seven thoracic surgeons participated in this two-year survey study after completing a one-time demographic survey. Each time a surgeon ordered a nonvascular thoracic MR imaging study they were sent a link to the pre-test survey, which assessed the clinical rationale for imaging and pre-test diagnostic certainty. The surgeon was then sent a link to a post-test survey upon completion of the MR imaging report. Data were included from 99 pre- and post-test surveys.

The researchers found that 65 percent of MR imaging studies were requested due to indeterminate findings on computed tomography. MR imaging correlated with a significant reduction in the number of planned surgical interventions (P < 0.001), modified the surgical approach in more than half of cases (54 percent), and increased surgeon comfort with patient management in 95 percent of cases. As a result of MR imaging, increased diagnostic certainty was highly significant (P < 0.0001).

"In appropriate cases, assessment with nonvascular thoracic MR imaging substantially affects the clinical decision making and diagnostic certainty of thoracic surgeons," the authors write.

Several authors disclosed financial ties to the medical device industry.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

ASTRO: No Survival Benefit for Adding EBT to Brachytherapy

ASTRO: No Survival Benefit for Adding EBT to ...

Addition of external beam therapy doesn't improve five-year progression-free survival in prostate cancer

ASTRO: Fewer Side Effects With IMRT in Cervical, Endometrial CA

ASTRO: Fewer Side Effects With IMRT in Cervical, ...

Patients in conventional radiotherapy arm had more high-level adverse events than those in IMRT arm

Many Doctors Reluctant to Reveal Mental Health Issues

Many Doctors Reluctant to Reveal Mental Health Issues

Perceived stigma, fear of career repercussions hinder treatment, study suggests

is free, fast, and customized just for you!

Already a member?

Sign In Now »